Cannabis Chart Of The Week: Lenders Vs. Borrowers – The Wisdom Of Diversification
The chart shows the YTD stock performance of two equally weighted baskets of stocks.
Why Adobe’s Shares Are Trading Lower Monday
Adobe sees a dip in its shares following a lawsuit by the FTC, which accuses the company of not fully disclosing termination fees, thus trapping consumers in costly year-long subscriptions.
Why Is Pfizer Partner BioNTech Stock Trading Lower On Monday?
BioNTech partner MediLink Therapeutics faces a partial clinical hold from the FDA on the Phase 1 trial of BNT326/YL202 for advanced non-small cell lung cancer and HR+/HER2-negative breast cancer.
Pfizer’s COVID-19 Vaccine Safety Claims Under Lens, Faces Lawsuit From Kansas For Alleged Misleading Claims
Kansas has filed a lawsuit against Pfizer, Inc., alleging the company misled the public about the safety and effectiveness of its COVID-19 vaccine, resulting in consumer protection violations and record revenues.
Tesla Sues Former Supplier Over Trade Secret Theft, Seeks $1B Compensation: Report
In a significant legal move, Tesla Inc. is reportedly suing Matthews International, claiming the company misappropriated Tesla's proprietary dry electrode battery technology to the detriment of Tesla's competitive edge and innovation.
Why Xponential Fitness Shares Are Surging On Monday
Xponential Fitness announces Mark King as the new CEO effective June 17, 2024, boosting investor confidence. King, with a robust track record at Taco Bell and Adidas, aims to enhance global brand performance and franchise operations.
Detailed Data From Gilead Halted Blood Cancer Drug Magrolimab Program Shows Higher Deaths And Side Effects
Gilead's recent data from two Phase 3 trials show higher adverse events and lower transplant rates in patients treated with magrolimab.
Why EV Maker Polestar Automotive’s Shares Are Soaring Today
Shares of Polestar Automotive Holding are surging today after the company said it is expanding its global presence and enhancing its retail strategy to include both existing and new markets as its electric vehicle (EV) lineup grows.
What’s Happening With US Steel Shares On Monday?
U.S. Steel forecasts Q2 2024 adjusted net earnings per share of $0.76 to $0.80, under the consensus estimate of $0.83, amidst stable domestic demand but challenging market dynamics, as detailed by CEO David B. Burritt.
Mirum Pharmaceuticals Highlights Encouraging Data For Rare Liver Disease Therapy From Two Mid-Stage Studies
Mirum Pharmaceuticals announced promising interim results from Phase 2b studies of volixibat for primary biliary cholangitis and primary sclerosing cholangitis. Significant improvements in pruritus and fatigue were observed.